Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder leading to progressive motor neuron cell death. Etiopathogenesis is still imperfectly known and much effort have been undertaken to find a biological marker that could help in the early diagnosis and in the monitoring of disease progression. Cerebrospinal fluid (CSF) concentrations of tau, an axonal microtubule-associated protein, have been measured in ALS with levels found increased in some studies and unchanged in others. Methods: Total CSF tau level was assayed in a population of ALS patients (n= 57) and controls (n= 110) using a specific ELISA method. Results: No sig- nificant differences in the median CSF tau levels between ALS cases and controls were found [ALS: 126 pg/ml (78–222); controls: 112 pg/ml (71–188), P= ns]. In the ALS group, the bulbar-onset patients showed increased CSF tau levels as compared with the spinal-onset cases. These differences might be related to the higher age of the bulbar-onset patients. Further, no correlations were found between CSF tau con- centrations and the rate of progression of the disease. Conclusions: These results do not support the hypothesis that total CSF tau protein is a reliable biological marker for ALS

PALADINO, P., VALENTINO, F., PICCOLI, T., PICCOLI, F., LA BELLA, V. (2009). Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis. EUROPEAN JOURNAL OF NEUROLOGY, 16(2), 257-261 [10.1111/j.1468-1331.2008.02405.x].

Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.

PALADINO, Piera;VALENTINO, Francesca;PICCOLI, Tommaso;LA BELLA, Vincenzo
;
PICCOLI, Federico
2009-01-14

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder leading to progressive motor neuron cell death. Etiopathogenesis is still imperfectly known and much effort have been undertaken to find a biological marker that could help in the early diagnosis and in the monitoring of disease progression. Cerebrospinal fluid (CSF) concentrations of tau, an axonal microtubule-associated protein, have been measured in ALS with levels found increased in some studies and unchanged in others. Methods: Total CSF tau level was assayed in a population of ALS patients (n= 57) and controls (n= 110) using a specific ELISA method. Results: No sig- nificant differences in the median CSF tau levels between ALS cases and controls were found [ALS: 126 pg/ml (78–222); controls: 112 pg/ml (71–188), P= ns]. In the ALS group, the bulbar-onset patients showed increased CSF tau levels as compared with the spinal-onset cases. These differences might be related to the higher age of the bulbar-onset patients. Further, no correlations were found between CSF tau con- centrations and the rate of progression of the disease. Conclusions: These results do not support the hypothesis that total CSF tau protein is a reliable biological marker for ALS
Settore MED/26 - Neurologia
PALADINO, P., VALENTINO, F., PICCOLI, T., PICCOLI, F., LA BELLA, V. (2009). Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis. EUROPEAN JOURNAL OF NEUROLOGY, 16(2), 257-261 [10.1111/j.1468-1331.2008.02405.x].
File in questo prodotto:
File Dimensione Formato  
Paladino et al. - 2009 - Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.pdf

Solo gestori archvio

Descrizione: main article
Dimensione 184.8 kB
Formato Adobe PDF
184.8 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/71827
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 24
social impact